Key result
18F-FDG PET/CT successfully detected a rare right ventricular metastasis in a 71-year-old man with squamous cell lung carcinoma.
Case Report (n=1)
18F-FDG PET/CT is an effective imaging modality for detecting rare cardiac metastases in patients with lung cancer, which can guide subsequent clinical management.
May facilitate detection of rare cardiac metastases in lung cancer; hypothesis-generating and should not yet change practice.
Lung cancer is currently one of the most common malignancies worldwide. Among all metastatic sites of this cancer, cardiac metastases are exceptional, and long-term prognosis in these patients is very poor. 18F-FDG PET/CT is a valuable imaging tool for initial staging and assessment of treatment response of various neoplasms. In the case of lung cancer, its role is clearly defined, and its effectiveness is superior to other diagnostic imaging methods. We present a rare 18F-FDG PET/CT image finding in a 71-year-old man with biopsy-proven lung squamous cell carcinoma, showing increased cardiac 18F-FDG uptake subsequently found to be compatible cardiac metastasis.
No takes yet. Share an insight, caveat, or question.
Benameur et al. (2023) conducted a case report in Lung squamous cell carcinoma with cardiac metastasis (n=1). 18F-FDG PET/CT was evaluated on Detection of cardiac metastasis. 18F-FDG PET/CT successfully detected a rare right ventricular metastasis in a 71-year-old man with squamous cell lung carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: